Final Results of a Prospective Phase 2 Study of Adding Erlotinib to Chemoradiation for patients With Stage III Non-small Cell Lung Cancer

被引：0
作者：
Komaki, R. U. [1 ]
Allen, P. K. [1 ]
Wei, X. [1 ]
Blumenschein, G. R. [2 ]
XiMing, T. [3 ]
Lee, J. J. [3 ]
Welsh, J. W. [1 ]
Wistuba, I. [4 ]
Liu, D. D. [3 ]
Meyn, R. [5 ]
Hong, W. K. [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Thorac Med Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.1725
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3113
引用
收藏
页码：E470 / E470
页数：1
相关论文
共 50 条
  • [41] Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small cell lung cancer: Results of a phase 1/2 trial: Comment
    Chang, Joe Y.
    International Journal of Radiation Oncology Biology Physics, 2013, 87 (01): : 2 - 4
  • [42] Concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase I study
    Cardenal, Felipe
    Arnaiz, Ma Dolores
    Moran, Teresa
    Jove, Josep
    Sole, Josep Ma
    Porta, Ruth
    Nadal, Ernest
    Brao, Isabel
    Palmero, Ramon
    Fuentes, Rafael
    Nunez, Inmaculada
    Cassinello, Alejo
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S849 - S849
  • [43] Erlotinib in First-line Therapy for Non-small Cell Lung Cancer: A Prospective Phase II Study
    Choi, Dae Ro
    Lee, Dae Ho
    Choi, Chang-Min
    Kim, Sang-We
    Suh, Cheolwon
    Lee, Jung-Shin
    ANTICANCER RESEARCH, 2011, 31 (10) : 3457 - 3462
  • [44] Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study (vol 3, 2017)
    Chang, J. Y.
    Verma, V.
    Li, M.
    JAMA ONCOLOGY, 2017, 3 (09) : 1286 - 1286
  • [45] Vimentin (EMT Marker Protein) Score Predicts Resistance to Erlotinib and Radiotherapy for Patients with Stage III Non-Small Cell Lung Cancer on A Prospective Phase II Trial
    Komaki, R. U.
    Kim, Y. B.
    Wistuba, I. I.
    Tang, X.
    Meyn, R.
    Allen, P. K.
    Wei, X.
    Lee, J. J.
    O'Reilly, M. S.
    Hong, W. K.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S220 - S220
  • [46] Preoperative chemoradiotherapy for stage III unresectable non-small cell lung cancer: Results of a phase II study.
    Reboul, F
    Chauvin, G
    Vincent, P
    Brewer, Y
    FelixFaure, C
    Taulelle, M
    BULLETIN DU CANCER, 1996, 83 (04) : 300 - 306
  • [47] Consolidation Chemotherapy with Docetaxel Following Concurrent Chemoradiation in Stage III Non-Small Cell Lung Cancer - Results of the Phase III Study of the Hoosier Oncology Group and US Oncology
    Semrau, Sabine
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (07) : 477 - 479
  • [48] IMPACT AND SAFETY PROFILE OF ERLOTINIB TREATMENT IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER - A SMALL PROSPECTIVE STUDY
    Mazilu, Laura
    Iorga, Polixenia
    Suceveanu, Andra-Iulia
    Parepa, Irinel
    Suceveanu, Adrian
    Tofolean, Doina
    Adam, Tatiana
    Jinga, Dan
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1234 - S1234
  • [49] Stage and treatment migration in patients with stage III non-small cell lung cancer
    Hubbs, J. L.
    Fatunase, T.
    Hollis, D. R.
    Clough, R. W.
    Kelsey, C. R.
    D'Amico, T. A.
    Marks, L. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S159 - S160
  • [50] Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
    Ou, Sai-Hong Ignatius
    Govindan, Ramaswamy
    Eaton, Keith D.
    Otterson, Gregory A.
    Gutierrez, Martin E.
    Mita, Alain C.
    Argiris, Athanassios
    Brega, Nicoletta M.
    Usari, Tiziana
    Tan, Weiwei
    Ho, Steffan N.
    Robert, Francisco
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : 145 - 151
12345